Loading clinical trials...
Loading clinical trials...
The study hypothesis is that new imaging agents \[203Pb\]VMT01 and \[68Ga\]VMT02 can be safely used in humans without independent biological effect and can be used to image melanoma tumors expressing ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Perspective Therapeutics
Collaborators
NCT06425926 · Melanoma Stage IV, Solid Tumor
NCT05655312 · Recurrent Melanoma (Skin), Metastatic Melanoma, and more
NCT06956690 · Melanoma (Skin), Non Small Cell Lung Cancer, and more
NCT03340129 · Melanoma Stage Iv
NCT04562129 · Melanoma Stage III, Melanoma Stage IV, and more
Mayo Clinic
Rochester, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions